Antiepiligrin cicatricial pemphigoid (AECP) is a chronic autoimmune subepidermal blistering disease characterized by clinical features of cicatricial pemphigoid and circulating IgG antibasement membrane autoantibodies directed against laminin 332. There is growing evidence of an increased relative risk for solid cancers and lymphomas in AECP patients, especially in the 1 st year after the onset of blisters.
Introduction
Antiepiligrin cicatricial pemphigoid (AECP) is a mucosapredominant autoimmune subepidermal blistering disease that is clinically indistinguishable from other forms of cicatricial pemphigoid 1 (CP). The importance of defining AECP within the spectrum of mucosa-predominant blistering diseases by immunoblot, immunoprecipitation, or indirect immunofluorescence (IF) using antigen-deficient skin substrates 2, 3 is emphasized by its association with cancer and increased cancer-related morbidity and mortality. 4e6 This report is of a case of initially skin-predominant AECP, which is distinguished from epidermolysis bullosa acquisita (EBA) using indirect IF of Type VII collagen-and laminin 332-deficient skin as substrates. The clinical course and histo-and immunopathologic findings are presented.
Case report
A 33-year-old male patient presented with a 1-month history of multiple pruritic tense blisters overlying the erythematous bases initially on the dorsum of both hands and feet, then centripetally spreading to both arms, thighs, and trunk without mucosal lesions. His past history was unremarkable except for gout under treatment with colchicine and benzbromazone for several years. Laboratory findings showed negative antinuclear antibody (<1:40), rheumatoid factor, and other autoimmune profiles. The patient also did not fulfill the American Rheumatism Association criteria for systemic lupus erythematosus (LE). Histological examination of the cutaneous biopsy specimens revealed subepidermal blister with predominant neutrophilic infiltration mixed with some eosinophils (Figure 1 ). Direct IF showed linear C3 and IgG deposition along the basement membrane zone (BMZ), whereas indirect IF revealed circulating IgG antibasement membrane autoantibodies binding to dermal floor of the 1M NaCl split skin 7 ( Figure 2 ). With a tentative diagnosis of EBA, prednisolone 0.7 mg/kg/d was started. However, progressive blisters on the trunk and four extremities with concurrent oral and genital mucosal erosions developed after 2 weeks, and some blisters ruptured with scarring and milia formation ( Figures 3A and 3B ). Indirect IF on antigen-deficient skin substrates showed positive reactions with the BMZ on Type VII collagen-deficient skin and negative findings on laminin 332-deficient skin 2, 3 ( Figures 4A and 4B ), leading to a diagnosis of AECP.
The patient was then shifted to azathioprine 150 mg/d and prednisone 1 mg/kg/d, with good control. Further work-up for malignancy, including serologic tumor markers, chest X-rays, abdominal ultrasound, panendoscopy, and colon fiberscopy, were negative. The patient was in his stable condition during treatment for about half a year, but he was loss to follow-up thereafter.
Discussion
CP, also known as mucous membrane pemphigoid, is an autoimmune subepidermal blistering disease predominantly involving the mucous membrane and occasionally involving the skin in up to 30% of patients. 1 Patients with CP exhibit IgG and/or IgA autoantibodies directed against heterogeneous components of the BMZ, including BPAG1, BPAG2, laminin 332, Type VII collagen, a6-integrin subunit, or b4-integrin subunit. 1, 5 Indirect IF studies of 1M NaCl split skin
show that IgG autoantibodies from CP patients can bind to the epidermal side, dermal side, and even both sides of test substrates, depending on which autoantigens are the targets. It is estimated to comprise 5e20% of CP cases. 5 It typically affects the elderly, with the median age of onset at 65 years and occurs with equal frequency in men and women. 4, 5 The clinical features of AECP are characterized by erosive and/or vesiculobullous lesions that usually heal with scarring and tissue destruction. Mucosal sites most commonly involved are the mouth and eyes. 5 Other mucosal sites, including the nose, pharynx, larynx, esophagus, and anogenital region, are less commonly involved. However, skin involvement is not a dominant feature. 5 Direct IF studies of perilesional mucous membrane or skin biopsy specimen show linear deposits composed mainly of IgG, and sometimes C3, in the epidermal BMZ. 5 Indirect IF studies reveal binding of IgG antibasement membrane autoantibodies exclusively to the dermal side of 1M NaCl split skin.
1,5
Figure 1 A subepidermal blister with predominant neutrophilic infiltration mixed with some eosinophils on the right forearm (hematoxylin-eosin stain, Â200). The presence of antilaminin 332 autoantibodies is essential for the diagnosis of AECP. 5 We reviewed the literatures about anti- The mechanism of association of AECP with cancer is still unknown, but laminin 332 seems to play a central role. 5 Laminin 332, a heterotrimeric adhesion protein consisting of a3b3g2 subunits, is expressed in the basement membrane of normal epithelia and in the extracellular matrix of various malignancies.
5
AECP is considered a paraneoplastic syndrome, a condition characterized by an autoimmune response to laminin 332 present in both normal skin and the underlying malignancy. 5 This is supported by observations that clinical disease activity of AECP correlates with total tumor mass. 1, 5 That is, the clinical disease activity of AECP is markedly reduced when the primary tumor is partially or completely removed, and metastasis or cancer recurrence is associated with recurrent or high disease activity. 1, 5 Treatment of all subsets of CP, including AECP, is similar. It depends on disease location, extent, and severity. 19 In limited mucosal or cutaneous lesions, topical or intralesional glucocorticoids with topical anesthetic agents and oral hygiene may suffice. 19 While in extensive or progressive disease, systemic agents are warranted as following. Dapsone and tetracycline have been reported to be effective in some patients. 19 If there is poor response to both agents, systemic glucocorticoid in combination with immunosuppressive agents, such as cyclophosphamide, azathioprine, or mycophenolate mofetil, are indicated. 19 High dose intravenous immunoglobulin is reserved for patients who are refractory to the above-mentioned therapies. 19 During treatment of AECP, early detection of solid cancer or lymphoma is important to decrease the cancer-related morbidity and mortality.
In conclusion, this is a report of a middle-aged male patient with an initial skin-predominant AECP, which was distinguished from EBA using indirect IF of Type VII collagen-and laminin 332-deficient skin. The patient had good response to systemic treatment with azathioprine and prednisolone. The relationship of AECP with cancers and the effect on prognosis warrant long-term follow-up.
